FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioids

21 organizations filed 21 public comments on FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioids, at the Food and Drug Administration. The comment window closed 3305d ago.

Commenters (21)

• Accreditation Council for Pharmacy Educationtrade assoc.

  1 filing · confidence 85%
• Acupuncture Now Foundationtrade assoc.

  1 filing · confidence 85%
• Acupuncture Society of Virginiatrade assoc.

  1 filing · confidence 85%
• American Academy of Pediatrics (AAP)

  1 filing · confidence 97%
• American Chiropractic Associationtrade assoc.

  1 filing · confidence 85%
• American Massage Therapy Associationtrade assoc.

  1 filing · confidence 85%
• American Medical Associationtrade assoc.

  1 filing · confidence 97%
• American Pharmacists Association (APhA)trade assoc.

  1 filing · confidence 97%
• American Physical Therapy Associationtrade assoc.

  1 filing · confidence 85%
• American Society of Acupuncturiststrade assoc.

  1 filing · confidence 85%
• American Society of Addiction Medicinetrade assoc.

  1 filing · confidence 85%
• American Society of Anesthesiologiststrade assoc.

  1 filing · confidence 85%
• American Society of Clinical Oncologytrade assoc.

  1 filing · confidence 85%
• American Traditional Chinese Medicine Associationtrade assoc.

  1 filing · confidence 85%
• Boston University School of Medicineunverified attribution

  1 filing · confidence 70%
• California Acupuncture Associationtrade assoc.

  1 filing · confidence 85%
• Egalet Corporationunverified attribution

  1 filing · confidence 70%
• International Chiropractors Associationtrade assoc.

  1 filing · confidence 85%
• National Association of Chain Drug Storestrade assoc.

  1 filing · confidence 97%
• National Safety Counciltrade assoc.

  1 filing · confidence 85%
• Ohio Association of Acupuncture and Oriental Medicinetrade assoc.

  1 filing · confidence 85%